Monte Rosa Therapeutics, Inc. Skyrocketed

Mon, Sep 15, 2025 at 07:34 PM

Monte Rosa Therapeutics, Inc. (GLUE:NASDAQ) soared at $6.93, representing a gain of 44.1%. On Mon, Sep 15, 2025, GLUE:NASDAQ hit a New 2-Week High of $6.93. The stock appeared on our News Catalysts scanner on Mon, Sep 15, 2025 at 10:30 AM in the 'PATNERSHIP' category. From Tue, Sep 02, 2025, the stock recorded 55.56% Up Days and 40.00% Green Days

About Monte Rosa Therapeutics, Inc. (GLUE:NASDAQ)

Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade...

Top 10 Gainers:

Check-Cap Ltd. (CHEK:NASDAQ), 185.83%
MetaVia Inc. (MTVA:NASDAQ), 115.55%
AVITA Medical, Inc. (RCEL:NASDAQ), 48.25%
Monte Rosa Therapeutics, Inc. (GLUE:NASDAQ), 44.07%
Lead Real Estate Co., Ltd (LRE:NASDAQ), 37.78%
Beeline Holdings, Inc. (BLNE:NASDAQ), 36.4%
Apollomics, Inc. (APLM:NASDAQ), 36.02%
Oriental Rise Holdings Limited (ORIS:NASDAQ), 35.33%
Yoshiharu Global Co. (YOSH:NASDAQ), 34.65%
C4 Therapeutics, Inc. (CCCC:NASDAQ), 34.21%